Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Moore

Showing results (201-210 of 269) with videos related to

Pageof 27
Sort By:
Journal of Virology|September 1, 1997
Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. offH Mo, L Stamatatos, J E Ip, et al.
Journal of Virology|October 17, 2001
Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5C E Parker, L J Deterding, C Hager-Braun, et al.
Journal of Virology|March 14, 1998
Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usageA Trkola, T Ketas, V N Kewalramani, et al.
Journal of Virology|August 3, 2001
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitroP W Parren, P A Marx, A J Hessell, et al.
AIDS Research and Human Retroviruses|April 1, 1992
Monoclonal antibodies to the C4 region of human immunodeficiency virus type 1 gp120: use in topological analysis of a CD4 binding siteJ A McKeating, J P Moore, M Ferguson, et al.
The Journal of Infectious Diseases|August 19, 2000
The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infectionJ M Binley, A Trkola, T Ketas, et al.
AIDS Research and Human Retroviruses|May 20, 1998
Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult bloodH Mo, S Monard, H Pollack, et al.
Nature Communications|July 8, 2025
Seasonal stabilization effects slowed the greening of the Northern Hemisphere over the last two decadesWen Zhang, William K Smith, Trevor F Keenan, et al.
Journal of Virology|March 14, 1998
Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usageD C Montefiori, R G Collman, T R Fouts, et al.
AIDS Research and Human Retroviruses|January 1, 1993
Identification of human immunodeficiency virus type 1 glycoprotein gp120/gp41 interacting sites by the idiotypic mimicry of two monoclonal antibodiesL Lopalco, R Longhi, F Ciccomascolo, et al.
Pageof 27

Showing results (201-210 of 269) with videos related to

Sort By:
Pageof 27
Journal of Virology|September 1, 1997
Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. offH Mo, L Stamatatos, J E Ip, et al.
Journal of Virology|October 17, 2001
Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5C E Parker, L J Deterding, C Hager-Braun, et al.
Journal of Virology|March 14, 1998
Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usageA Trkola, T Ketas, V N Kewalramani, et al.
Journal of Virology|August 3, 2001
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitroP W Parren, P A Marx, A J Hessell, et al.
AIDS Research and Human Retroviruses|April 1, 1992
Monoclonal antibodies to the C4 region of human immunodeficiency virus type 1 gp120: use in topological analysis of a CD4 binding siteJ A McKeating, J P Moore, M Ferguson, et al.
The Journal of Infectious Diseases|August 19, 2000
The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infectionJ M Binley, A Trkola, T Ketas, et al.
AIDS Research and Human Retroviruses|May 20, 1998
Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult bloodH Mo, S Monard, H Pollack, et al.
Nature Communications|July 8, 2025
Seasonal stabilization effects slowed the greening of the Northern Hemisphere over the last two decadesWen Zhang, William K Smith, Trevor F Keenan, et al.
Journal of Virology|March 14, 1998
Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usageD C Montefiori, R G Collman, T R Fouts, et al.
AIDS Research and Human Retroviruses|January 1, 1993
Identification of human immunodeficiency virus type 1 glycoprotein gp120/gp41 interacting sites by the idiotypic mimicry of two monoclonal antibodiesL Lopalco, R Longhi, F Ciccomascolo, et al.
Pageof 27